STEVENSON, Md.--(BUSINESS WIRE)--The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Omnicare, Inc. (“Omnicare” or the “Company”) (NYSE: OCR) relating to the proposed buyout of the Company by CVS Health Corporation, Inc. Under the terms of the transaction, Omnicare shareholders are anticipated to receive $98.00 in cash for each share